{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:20:02Z","timestamp":1774696802114,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J011237"],"award-info":[{"award-number":["2023J011237"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J011237"],"award-info":[{"award-number":["2023J011237"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J011237"],"award-info":[{"award-number":["2023J011237"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J011237"],"award-info":[{"award-number":["2023J011237"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J011237"],"award-info":[{"award-number":["2023J011237"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J011237"],"award-info":[{"award-number":["2023J011237"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fujian Provincial Health and Family Planning Research Talent Training Program","award":["2019-ZQN-15"],"award-info":[{"award-number":["2019-ZQN-15"]}]},{"name":"Fujian Provincial Health and Family Planning Research Talent Training Program","award":["2019-ZQN-15"],"award-info":[{"award-number":["2019-ZQN-15"]}]},{"name":"Fujian Provincial Health and Family Planning Research Talent Training Program","award":["2019-ZQN-15"],"award-info":[{"award-number":["2019-ZQN-15"]}]},{"name":"Fujian Provincial Health and Family Planning Research Talent Training Program","award":["2019-ZQN-15"],"award-info":[{"award-number":["2019-ZQN-15"]}]},{"name":"Fujian Provincial Health and Family Planning Research Talent Training Program","award":["2019-ZQN-15"],"award-info":[{"award-number":["2019-ZQN-15"]}]},{"name":"Fujian Provincial Health and Family Planning Research Talent Training Program","award":["2019-ZQN-15"],"award-info":[{"award-number":["2019-ZQN-15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12416-6","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T09:47:44Z","timestamp":1753436864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and efficacy of individualized modified total neoadjuvant therapy for low locally advanced rectal cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Qing","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinliang","family":"Jian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"issue":"3","key":"12416_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74(3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"12416_CR2","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1038\/s41598-025-86575-x","volume":"15","author":"C Liu","year":"2025","unstructured":"Liu, C., Chen, J. & Liu, Y. Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: A retrospective study. Sci. Rep. 15(1), 4237 (2025).","journal-title":"Sci. Rep."},{"issue":"11","key":"12416_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037484","volume":"103","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Identification and prognostic analysis of candidate biomarkers for lung metastasis in colorectal cancer. Medicine (Baltimore) 103(11), e37484 (2024).","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"12416_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","volume":"12","author":"W van Gijn","year":"2011","unstructured":"van Gijn, W. et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 12(6), 575\u2013582 (2011).","journal-title":"Lancet Oncol."},{"issue":"3","key":"12416_CR5","first-page":"226","volume":"35","author":"AA Iv","year":"2022","unstructured":"Iv, A. A. et al. The evolution of rectal cancer treatment: The journey to total neoadjuvant therapy and organ preservation. Ann. Gastroenterol. 35(3), 226\u2013233 (2022).","journal-title":"Ann. Gastroenterol."},{"issue":"1","key":"12416_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13062-022-00329-7","volume":"17","author":"AM Guida","year":"2022","unstructured":"Guida, A. M. et al. Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: A systematic minireview. Biol. Direct. 17(1), 16 (2022).","journal-title":"Biol. Direct."},{"issue":"8","key":"12416_CR7","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","volume":"16","author":"C R\u00f6del","year":"2015","unstructured":"R\u00f6del, C. et al. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 16(8), 979\u2013989 (2015).","journal-title":"Lancet Oncol."},{"issue":"6","key":"12416_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0071","volume":"4","author":"A Cercek","year":"2018","unstructured":"Cercek, A. et al. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncol. 4(6), e180071 (2018).","journal-title":"JAMA Oncol."},{"issue":"8","key":"12416_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","volume":"16","author":"J Garcia-Aguilar","year":"2015","unstructured":"Garcia-Aguilar, J. et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: A multicentre, phase 2 trial. Lancet Oncol. 16(8), 957\u2013966 (2015).","journal-title":"Lancet Oncol."},{"issue":"8","key":"12416_CR10","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/annonc\/mdz186","volume":"30","author":"B Cise\u0142","year":"2019","unstructured":"Cise\u0142, B. et al. Long-course preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: Long-term results of the randomized Polish II study. Ann. Oncol. 30(8), 1298\u20131303 (2019).","journal-title":"Ann. Oncol."},{"issue":"4","key":"12416_CR11","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1097\/SLA.0000000000005799","volume":"278","author":"EA Dijkstra","year":"2023","unstructured":"Dijkstra, E. A. et al. Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial. Ann. Surg. 278(4), e766\u2013e772 (2023).","journal-title":"Ann. Surg."},{"issue":"5","key":"12416_CR12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1200\/JCO.2009.25.8541","volume":"28","author":"C Fern\u00e1ndez-Martos","year":"2010","unstructured":"Fern\u00e1ndez-Martos, C. et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J. Clin. Oncol. 28(5), 859\u2013865 (2010).","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"12416_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/SLA.0000000000003471","volume":"271","author":"F Petrelli","year":"2020","unstructured":"Petrelli, F. et al. Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes. Ann. Surg. 271(3), 440\u2013448 (2020).","journal-title":"Ann. Surg."},{"issue":"11","key":"12416_CR14","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/bjs.11352","volume":"106","author":"A Zaborowski","year":"2019","unstructured":"Zaborowski, A., Stakelum, A. & Winter, D. C. Author response to: Total neoadjuvant therapy in rectal cancer-improvement or overtreatment?. Br. J. Surg. 106(11), 1558 (2019).","journal-title":"Br. J. Surg."},{"issue":"34","key":"12416_CR15","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1200\/JCO.19.00308","volume":"37","author":"E Fokas","year":"2019","unstructured":"Fokas, E. et al. Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO\/ARO\/AIO-12. J. Clin. Oncol. 37(34), 3212\u20133222 (2019).","journal-title":"J. Clin. Oncol."},{"key":"12416_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102177","volume":"96","author":"EF Giunta","year":"2021","unstructured":"Giunta, E. F. et al. Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials. Cancer Treat. Rev. 96, 102177 (2021).","journal-title":"Cancer Treat. Rev."},{"issue":"17","key":"12416_CR17","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1200\/JCO.2015.60.8554","volume":"33","author":"TS Hong","year":"2015","unstructured":"Hong, T. S. & Ryan, D. P. Adjuvant Chemotherapy for Locally Advanced Rectal Cancer: Is It a Given?. J. Clin. Oncol. 33(17), 1878\u20131880 (2015).","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"12416_CR18","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/bjs.11353","volume":"106","author":"P Mroczkowski","year":"2019","unstructured":"Mroczkowski, P. & Dziki, L. Total neoadjuvant therapy in rectal cancer - improvement or overtreatment?. Br. J. Surg. 106(11), 1558 (2019).","journal-title":"Br. J. Surg."},{"issue":"11","key":"12416_CR19","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/jamaoncol.2019.2294","volume":"5","author":"C Fern\u00e1ndez-Martos","year":"2019","unstructured":"Fern\u00e1ndez-Martos, C. et al. Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial. JAMA Oncol. 5(11), 1566\u20131573 (2019).","journal-title":"JAMA Oncol."},{"issue":"9","key":"12416_CR20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/cncr.30600","volume":"123","author":"EB Ludmir","year":"2017","unstructured":"Ludmir, E. B. et al. Total neoadjuvant therapy for rectal cancer: An emerging option. Cancer 123(9), 1497\u20131506 (2017).","journal-title":"Cancer"},{"issue":"15","key":"12416_CR21","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1200\/JCO.21.01667","volume":"40","author":"J Jin","year":"2022","unstructured":"Jin, J. et al. Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR). J. Clin. Oncol. 40(15), 1681\u20131692 (2022).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"12416_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer, R. R. et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): A randomised, open-label, phase 3 trial. Lancet Oncol. 22(1), 29\u201342 (2021).","journal-title":"Lancet Oncol."},{"issue":"7","key":"12416_CR23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/bjs.9112","volume":"100","author":"DA Sloothaak","year":"2013","unstructured":"Sloothaak, D. A. et al. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br. J. Surg. 100(7), 933\u2013939 (2013).","journal-title":"Br. J. Surg."},{"issue":"3","key":"12416_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/codi.14867","volume":"22","author":"C Terzi","year":"2020","unstructured":"Terzi, C. et al. Randomized controlled trial of 8 weeks\u2019 vs 12 weeks\u2019 interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer. Colorectal. Dis. 22(3), 279\u2013288 (2020).","journal-title":"Colorectal. Dis."},{"issue":"1","key":"12416_CR25","doi-asserted-by":"publisher","first-page":"10008","DOI":"10.1038\/s41598-019-46457-5","volume":"9","author":"YJ Lim","year":"2019","unstructured":"Lim, Y. J., Kim, Y. & Kong, M. Adjuvant chemotherapy in rectal cancer patients who achieved a pathological complete response after preoperative chemoradiotherapy: A systematic review and meta-analysis. Sci. Rep. 9(1), 10008 (2019).","journal-title":"Sci. Rep."},{"issue":"7","key":"12416_CR26","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/jamaoncol.2017.5597","volume":"4","author":"F Dossa","year":"2018","unstructured":"Dossa, F. et al. Association Between Adjuvant Chemotherapy and Overall Survival in Patients With Rectal Cancer and Pathological Complete Response After Neoadjuvant Chemotherapy and Resection. JAMA Oncol. 4(7), 930\u2013937 (2018).","journal-title":"JAMA Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12416-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:14:21Z","timestamp":1757286861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12416-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12416"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12416-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethics committee of Fujian Cancer Hospital. All methods were carried out in accordance with relevant guidelines and regulations. The informed consent was obtained from all subjects and\/or their legal guardian(s).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"We have obtained consent from all authors and participants, and they have agreed to publish the results of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"27068"}}